Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street's expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs it expects to deliver longterm growth. The pharmaceutical giant also raised its full-year revenue guidance for the year, expecting sales to increase by more than 5%. Bristol Myers ...